Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
1.
J Pineal Res ; 70(3): e12713, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33368564

RESUMEN

The human pineal gland regulates day-night dynamics of multiple physiological processes, especially through the secretion of melatonin. Using mass-spectrometry-based proteomics and dedicated analysis tools, we identify proteins in the human pineal gland and analyze systematically their variation throughout the day and compare these changes in the pineal proteome between control specimens and donors diagnosed with autism. Results reveal diverse regulated clusters of proteins with, among others, catabolic carbohydrate process and cytoplasmic membrane-bounded vesicle-related proteins differing between day and night and/or control versus autism pineal glands. These data show novel and unexpected processes happening in the human pineal gland during the day/night rhythm as well as specific differences between autism donor pineal glands and those from controls.


Asunto(s)
Trastorno Autístico/metabolismo , Ritmo Circadiano , Glándula Pineal/metabolismo , Proteínas/metabolismo , Proteoma , Proteómica , Espectrometría de Masa por Ionización de Electrospray , Espectrometría de Masas en Tándem , Trastorno Autístico/diagnóstico , Trastorno Autístico/fisiopatología , Trastorno Autístico/psicología , Estudios de Casos y Controles , Humanos , Glándula Pineal/fisiopatología , Mapas de Interacción de Proteínas , Factores de Tiempo
2.
J Immunol ; 198(6): 2468-2478, 2017 03 15.
Artículo en Inglés | MEDLINE | ID: mdl-28148733

RESUMEN

Numerous publications have addressed CD147 as a tumor marker and regulator of cytoskeleton, cell growth, stress response, or immune cell function; however, the molecular functionality of CD147 remains incompletely understood. Using affinity purification, mass spectrometry, and phosphopeptide enrichment of isotope-labeled peptides, we examined the dynamic of the CD147 microenvironment and the CD147-dependent phosphoproteome in the Jurkat T cell line upon treatment with T cell stimulating agents. We identified novel dynamic interaction partners of CD147 such as CD45, CD47, GNAI2, Lck, RAP1B, and VAT1 and, furthermore, found 76 CD147-dependent phosphorylation sites on 57 proteins. Using the STRING protein network database, a network between the CD147 microenvironment and the CD147-dependent phosphoproteins was generated and led to the identification of key signaling hubs around the G proteins RAP1B and GNB1, the kinases PKCß, PAK2, Lck, and CDK1, and the chaperone HSPA5. Gene ontology biological process term analysis revealed that wound healing-, cytoskeleton-, immune system-, stress response-, phosphorylation- and protein modification-, defense response to virus-, and TNF production-associated terms are enriched within the microenvironment and the phosphoproteins of CD147. With the generated signaling network and gene ontology biological process term grouping, we identify potential signaling routes of CD147 affecting T cell growth and function.


Asunto(s)
Basigina/metabolismo , Biomarcadores de Tumor/metabolismo , Citoesqueleto/metabolismo , Proteína Tirosina Quinasa p56(lck) Específica de Linfocito/metabolismo , Complejos Multiproteicos/metabolismo , Proteómica , Linfocitos T/fisiología , Basigina/genética , Procesos de Crecimiento Celular , Chaperón BiP del Retículo Endoplásmico , Proteínas de Unión al GTP/metabolismo , Ontología de Genes , Técnicas de Transferencia de Gen , Humanos , Células Jurkat , Activación de Linfocitos , Fosforilación , Unión Proteica , Transducción de Señal , Estrés Fisiológico
3.
J Immunol ; 196(3): 1387-99, 2016 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-26729804

RESUMEN

The Ig superfamily member CD147 is upregulated following T cell activation and was shown to serve as a negative regulator of T cell proliferation. Thus, Abs targeting CD147 are being tested as new treatment strategies for cancer and autoimmune diseases. How CD147 mediates immunosuppression and whether association with other coreceptor complexes is needed have remained unknown. In the current study, we show that silencing of CD147 in human T cells increases IL-2 production without affecting the TCR proximal signaling components. We mapped the immunosuppressive moieties of CD147 to its transmembrane domain and Ig-like domain II. Using affinity purification combined with mass spectrometry, we determined the domain specificity of CD147 interaction partners and identified the calcium exporter plasma membrane calcium ATPase isoform 4 (PMCA4) as the interaction partner of the immunosuppressive moieties of CD147. CD147 does not control the proper membrane localization of PMCA4, but PMCA4 is essential for the CD147-dependent inhibition of IL-2 expression via a calcium-independent mechanism. In summary, our data show that CD147 interacts via its immunomodulatory domains with PMCA4 to bypass TCR proximal signaling and inhibit IL-2 expression.


Asunto(s)
Basigina/inmunología , Interleucina-2/biosíntesis , Activación de Linfocitos/inmunología , ATPasas Transportadoras de Calcio de la Membrana Plasmática/inmunología , Receptores de Antígenos de Linfocitos T/inmunología , Linfocitos T/inmunología , Separación Celular , Citometría de Flujo , Humanos , Immunoblotting , Interleucina-2/inmunología , Células Jurkat , Espectrometría de Masas , Reacción en Cadena en Tiempo Real de la Polimerasa , Transducción de Señal/inmunología , Transducción Genética
4.
J Immunol ; 193(6): 2718-32, 2014 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-25127865

RESUMEN

The spatial and temporal organization of T cell signaling molecules is increasingly accepted as a crucial step in controlling T cell activation. CD222, also known as the cation-independent mannose 6-phosphate/insulin-like growth factor 2 receptor, is the central component of endosomal transport pathways. In this study, we show that CD222 is a key regulator of the early T cell signaling cascade. Knockdown of CD222 hampers the effective progression of TCR-induced signaling and subsequent effector functions, which can be rescued via reconstitution of CD222 expression. We decipher that Lck is retained in the cytosol of CD222-deficient cells, which obstructs the recruitment of Lck to CD45 at the cell surface, resulting in an abundant inhibitory phosphorylation signature on Lck at the steady state. Hence, CD222 specifically controls the balance between active and inactive Lck in resting T cells, which guarantees operative T cell effector functions.


Asunto(s)
Antígenos Comunes de Leucocito/inmunología , Activación de Linfocitos/inmunología , Proteína Tirosina Quinasa p56(lck) Específica de Linfocito/inmunología , Receptor IGF Tipo 2/inmunología , Linfocitos T/inmunología , Animales , Línea Celular Tumoral , Humanos , Células Jurkat , Activación de Linfocitos/genética , Proteína Tirosina Quinasa p56(lck) Específica de Linfocito/genética , Proteínas de Transporte de Membrana/inmunología , Ratones , Fosforilación , Interferencia de ARN , ARN Interferente Pequeño , Receptor IGF Tipo 2/biosíntesis , Receptor IGF Tipo 2/genética , Receptores de Antígenos de Linfocitos T/inmunología , Transducción de Señal/inmunología
5.
EMBO Rep ; 12(3): 259-66, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21311561

RESUMEN

A characteristic of integrins is their ability to transfer chemical and mechanical signals across the plasma membrane. Force generated by myosin II makes cells able to sense substrate stiffness and induce maturation of nascent adhesions into focal adhesions. In this paper, we present a comprehensive proteomic analysis of nascent and mature adhesions. The purification of integrin adhesion complexes combined with quantitative mass spectrometry enabled the identification and quantification of known and new adhesion-associated proteins. Furthermore, blocking adhesion maturation with the myosin II inhibitor blebbistatin markedly impaired the recruitment of LIM domain proteins to integrin adhesion sites. This suggests a common recruitment mechanism for a whole class of adhesion-associated proteins, involving myosin II and the zinc-finger-type LIM domain.


Asunto(s)
Adhesiones Focales/metabolismo , Integrinas/metabolismo , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Miosina Tipo II/metabolismo , Animales , Adhesión Celular , Células Cultivadas , Proteínas de la Matriz Extracelular/genética , Proteínas de la Matriz Extracelular/metabolismo , Adhesiones Focales/genética , Compuestos Heterocíclicos de 4 o más Anillos/farmacología , Péptidos y Proteínas de Señalización Intracelular/química , Espectrometría de Masas , Ratones , Miosina Tipo II/antagonistas & inhibidores , Proteómica , Transducción de Señal , Dedos de Zinc
6.
Mol Pharmacol ; 77(4): 547-58, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20061446

RESUMEN

Glucose-dependent insulinotropic polypeptide receptor (GIPR), a member of family B of the G-protein coupled receptors, is a potential therapeutic target for which discovery of nonpeptide ligands is highly desirable. Structure-activity relationship studies indicated that the N-terminal part of glucose-dependent insulinotropic polypeptide (GIP) is crucial for biological activity. Here, we aimed at identification of residues in the GIPR involved in functional interaction with N-terminal moiety of GIP. A homology model of the transmembrane core of GIPR was constructed, whereas a three-dimensional model of the complex formed between GIP and the N-terminal extracellular domain of GIPR was taken from the crystal structure. The latter complex was docked to the transmembrane domains of GIPR, allowing in silico identification of putative residues of the agonist binding/activation site. All mutants were expressed at the surface of human embryonic kidney 293 cells as indicated by flow cytometry and confocal microscopy analysis of fluorescent GIP binding. Mutation of residues Arg183, Arg190, Arg300, and Phe357 caused shifts of 76-, 71-, 42-, and 16-fold in the potency to induce cAMP formation, respectively. Further characterization of these mutants, including tests with alanine-substituted GIP analogs, were in agreement with interaction of Glu3 in GIP with Arg183 in GIPR. Furthermore, they strongly supported a binding mode of GIP to GIPR in which the N-terminal moiety of GIP was sited within transmembrane helices (TMH) 2, 3, 5, and 6 with biologically crucial Tyr1 interacting with Gln224 (TMH3), Arg300 (TMH5), and Phe357 (TMH6). These data represent an important step toward understanding activation of GIPR by GIP, which should facilitate the rational design of therapeutic agents.


Asunto(s)
Polipéptido Inhibidor Gástrico/química , Receptores de la Hormona Gastrointestinal/química , Secuencia de Aminoácidos , Células Cultivadas , AMP Cíclico/biosíntesis , Humanos , Ligandos , Modelos Biológicos , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Estructura Secundaria de Proteína
7.
Mol Pharmacol ; 75(3): 502-13, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19064631

RESUMEN

Signaling of G protein-coupled receptors (GPCRs) is regulated by different mechanisms. One of these involves regulators of G protein signaling (RGS), which are diverse and multifunctional proteins that bind to active Galpha subunits of G proteins and act as GTPase-activating proteins. Little is known about the molecular mechanisms that govern the selective use of RGS proteins in living cells. We first demonstrated that CCK2R-mediated inositol phosphate production, known to be G(q)-dependent, is more sensitive to RGS2 than to RGS4 and is insensitive to RGS8. Both basal and agonist-stimulated activities of the CCK2R are regulated by RGS2. By combining biochemical, functional, and in silico structural approaches, we demonstrate that a direct and functional interaction occurs between RGS2 and agonist-stimulated cholecystokinin receptor-2 (CCK2R) and identified the precise residues involved: phosphorylated Ser434 and Thr439 located in the C-terminal tail of CCK2R and Lys62, Lys63, and Gln67, located in the N-terminal domain of RGS2. These findings confirm previous reports that RGS proteins can interact with GPCRs to modulate their signaling and provide a molecular basis for RGS2 recognition by the CCK2R.


Asunto(s)
Fragmentos de Péptidos/fisiología , Proteínas RGS/fisiología , Receptor de Colecistoquinina B/fisiología , Transducción de Señal/fisiología , Secuencias de Aminoácidos/fisiología , Secuencia de Aminoácidos , Animales , Células COS , Chlorocebus aethiops , Humanos , Datos de Secuencia Molecular , Fragmentos de Péptidos/química , Fragmentos de Péptidos/metabolismo , Fosforilación/fisiología , Unión Proteica/fisiología , Proteínas RGS/química , Proteínas RGS/metabolismo , Receptor de Colecistoquinina B/química , Receptor de Colecistoquinina B/metabolismo
8.
Antioxid Redox Signal ; 10(1): 113-25, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17961005

RESUMEN

Native collagens are molecules that are difficult to handle because of their high tendency towards aggregation and denaturation. It was discovered early on that synthetic collagenous peptides are more amenable to conformational characterization and thus can serve as useful models for structural and functional studies. Single-stranded collagenous peptides of high propensity to self-associate into triple-helical trimers were used for this purpose as well as interchain-crosslinked homotrimers assembled on synthetic scaffolds. With the growing knowledge of the biosynthetic pathways of natural collagens and the importance of their interchain disulfide crosslinks, which stabilize the triple-helical structure, native as well as de novo designed cystine knots have gained increasing attention in the assembly of triple-stranded collagen peptides. In addition, natural sequences of collagens were incorporated in order to biophysically characterize their functional epitopes. This review is focused on the methods developed over the years, and future perspectives for the production of collagen-mimicking synthetic and recombinant triple-helical homo- and heterotrimers.


Asunto(s)
Colágeno/química , Cistina/química , Modelos Moleculares , Secuencia de Aminoácidos , Animales , Biopolímeros , Humanos , Datos de Secuencia Molecular , Homología de Secuencia de Aminoácido
9.
J Mol Biol ; 358(3): 846-56, 2006 May 05.
Artículo en Inglés | MEDLINE | ID: mdl-16530224

RESUMEN

The cysteine-rich N and C-terminal domains of minicollagen-1 from Hydra nematocysts fold with excesses of oxidized/reduced glutathione (10:1) into globular structures with distinct cystine frameworks despite their identical cysteine sequence pattern. An additional main difference is the cis conformation of a conserved proline residue in the N-terminal and the trans conformation of this residue in the C-terminal domain. Comparative analysis of the oxidative folding revealed for the C-terminal domain a fast and highly cooperative formation of a single disulfide isomer. Conversely, oxidation of the N-terminal domain proceeds mainly via an intermediate that results from the fast quasi-stochastic disulfide formation according to the proximity rule. The rate of conversion of the bead-like isomer into the globular end-product is largely dominated by the trans-to-cis isomerization of the critical proline residue as well assessed by its replacement with (4R)- and (4S)-fluoroproline known to exhibit distinct propensities for the trans and cis conformation, respectively. Independently, whether the trans or cis conformation is favored by these substitutions, both analogues retain sufficient sequence-encoded information to fold almost quantitatively into the identical cystine framework and thus spatial structure of the parent peptide with the critical proline residue as cis isomer, but at rates significantly lower for the (4R) than for the (4S)-fluoroproline analogue. Correspondingly, other sequence-encoded structural elements have to act as a driving force for these unidirectional folding pathways despite the rather simple sequence composition consisting only of aliphatic residues, some proline and only one aromatic residue (tyrosine) in the core parts of the C and N-terminal domains. The two cysteine-rich domains of minicollagen-1 may well represent ideal targets for ab initio structure calculations in order to learn more about the elementary information encoded in such primordial molecules.


Asunto(s)
Colágeno/química , Colágeno/metabolismo , Cisteína/metabolismo , Fragmentos de Péptidos/química , Fragmentos de Péptidos/metabolismo , Prolina/metabolismo , Pliegue de Proteína , Secuencia de Aminoácidos , Animales , Cromatografía Líquida de Alta Presión , Colágeno/genética , Cisteína/genética , Hydra/química , Hydra/genética , Hydra/metabolismo , Cinética , Espectroscopía de Resonancia Magnética , Modelos Moleculares , Datos de Secuencia Molecular , Oxidación-Reducción , Fragmentos de Péptidos/genética , Prolina/análogos & derivados , Prolina/genética , Estructura Terciaria de Proteína
10.
J Mol Biol ; 354(3): 591-600, 2005 Dec 02.
Artículo en Inglés | MEDLINE | ID: mdl-16257007

RESUMEN

Synthetic replicates of naturally occurring cysteine-rich peptides such as hormones, neurotransmitters, growth factors, enzyme inhibitors, defensins and toxins often can be oxidatively folded in high yields to their native structure in simple redox buffers. Thereby, identical cysteine patterns in the sequence were found to generate identical disulfide connectivities and homologous spatial structures despite significant variability in the non-cysteine positions. Minicollagen-1 from the nematocysts of Hydra is a trimeric protein that contains cysteine-rich domains at the N and C termini, which are involved in the assembly of an intermolecular disulfide network. Determination of the three-dimensional structures of peptides corresponding to the N-terminal and C-terminal domains by NMR spectroscopy revealed a remarkable exception from the general rule. Despite an identical cysteine pattern, the two domains of minicollagen-1 form different disulfide bridges and exhibit distinctly different folds, both of which are not found in the current structural databases. To our knowledge, this is the first case where two relatively short peptides with the abundant cysteine residues in identical sequence positions fold uniquely and with high yields into defined, but differing, structures. Therefore, the cysteine-rich domains of minicollagen constitute ideal model systems for studies of the interplay between folding and oxidation in proteins.


Asunto(s)
Colágeno/química , Colágeno/metabolismo , Cistina/metabolismo , Hydra/citología , Pliegue de Proteína , Secuencia de Aminoácidos , Animales , Cromatografía Líquida de Alta Presión , Cistina/química , Difusión , Disulfuros/química , Disulfuros/metabolismo , Hydra/química , Modelos Moleculares , Datos de Secuencia Molecular , Oxidación-Reducción , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína
11.
Cell Rep ; 14(11): 2653-67, 2016 Mar 22.
Artículo en Inglés | MEDLINE | ID: mdl-26972007

RESUMEN

Neuronal function is highly sensitive to changes in oxygen levels, but how hypoxia affects dendritic spine formation and synaptogenesis is unknown. Here we report that hypoxia, chemical inhibition of the oxygen-sensing prolyl hydroxylase domain proteins (PHDs), and silencing of Phd2 induce immature filopodium-like dendritic protrusions, promote spine regression, reduce synaptic density, and decrease the frequency of spontaneous action potentials independently of HIF signaling. We identified the actin cross-linker filamin A (FLNA) as a target of PHD2 mediating these effects. In normoxia, PHD2 hydroxylates the proline residues P2309 and P2316 in FLNA, leading to von Hippel-Lindau (VHL)-mediated ubiquitination and proteasomal degradation. In hypoxia, PHD2 inactivation rapidly upregulates FLNA protein levels because of blockage of its proteasomal degradation. FLNA upregulation induces more immature spines, whereas Flna silencing rescues the immature spine phenotype induced by PHD2 inhibition.


Asunto(s)
Espinas Dendríticas/metabolismo , Filaminas/metabolismo , Prolina Dioxigenasas del Factor Inducible por Hipoxia/metabolismo , Sinapsis/metabolismo , Aminoácidos Dicarboxílicos/farmacología , Animales , Hipoxia de la Célula , Línea Celular Tumoral , Células Cultivadas , Filaminas/antagonistas & inhibidores , Filaminas/genética , Células HEK293 , Hipocampo/citología , Hipocampo/metabolismo , Humanos , Subunidad alfa del Factor 1 Inducible por Hipoxia/genética , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Prolina Dioxigenasas del Factor Inducible por Hipoxia/antagonistas & inhibidores , Prolina Dioxigenasas del Factor Inducible por Hipoxia/genética , Ratones , Ratones Noqueados , Oxígeno/metabolismo , Ratas , Ratas Wistar , Tubulina (Proteína)/metabolismo , Regulación hacia Arriba/efectos de los fármacos , Proteína Supresora de Tumores del Síndrome de Von Hippel-Lindau/antagonistas & inhibidores , Proteína Supresora de Tumores del Síndrome de Von Hippel-Lindau/genética , Proteína Supresora de Tumores del Síndrome de Von Hippel-Lindau/metabolismo
12.
Biochem Biophys Res Commun ; 341(3): 715-20, 2006 Mar 17.
Artículo en Inglés | MEDLINE | ID: mdl-16434022

RESUMEN

There is an increasing interest towards the mechanism by which regulators of G-protein signaling regulate signals of G-protein-coupled receptors. RGS2 is a regulator of Gq protein signaling (RGS), the N-terminal region of which is known to contain determinants for G protein-coupled receptor recognition, but its structure is still unknown. To understand the molecular basis for this recognition, the three-dimensional model of RGS2, including N-terminal region and RGS box, was modeled. For this, RGS4 box structure and data from circular dichroism study of RGS2 N-terminal region were used. Then, membrane-targeting activity of the RGS2 amphipathic helix contained in the N-terminal region was investigated. Furthermore, in cellulo study provided first evidence that an internal sequence within the N-terminal region of RGS2 is involved in RGS2 regulation of cholecystokinin receptor-2 signal. RGS2 modeled structure can now serve to study molecular recognition of RGS2 by signaling molecules.


Asunto(s)
Proteínas RGS/química , Proteínas RGS/metabolismo , Animales , Células COS , Chlorocebus aethiops , Dicroismo Circular , Modelos Moleculares , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Proteínas RGS/genética
13.
J Mol Recognit ; 16(3): 131-8, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12833568

RESUMEN

Src homology-3 (SH3) domains mediate important protein-protein interactions in a variety of normal and pathological cellular processes, thus providing an attractive target for the selective interference of SH3-dependent signaling events that govern these processes. Most SH3 domains recognize proline-rich peptides with low affinity and poor selectivity, and the goal to design potent and specific ligands for various SH3 domains remains elusive. Better understanding of the molecular basis for SH3 domain recognition is needed in order to design such ligands with potency and specificity. In this report, we seek to define a clear recognition preference of the specificity pocket of the Abl SH3 domain using targeted synthetic peptide libraries. High-resolution affinity panning coupled with mass spectrometric readout allows for quick identification of Trp as the preferred fourth residue in the decapeptide ligand APTWSPPPPP, which binds to Abl SH3 four times stronger than does the decapeptide containing Tyr or Phe in the fourth position. This finding is in contrast to several reports that Tyr is the only residue selected from phage displayed peptide libraries that interacts with the specificity pocket of Abl SH3. This simple, unbiased approach can fine-tune the affinity and selectivity of both natural and unnatural SH3 ligands whose consensus binding sequence has been pre-defined by combinatorial library methods.


Asunto(s)
Proteínas Proto-Oncogénicas c-abl/química , Proteínas Proto-Oncogénicas c-abl/metabolismo , Dominios Homologos src , Cromatografía de Afinidad , Ligandos , Modelos Moleculares , Biblioteca de Péptidos , Unión Proteica , Pliegue de Proteína , Relación Estructura-Actividad , Especificidad por Sustrato , Volumetría
14.
Acta Crystallogr D Biol Crystallogr ; 59(Pt 7): 1165-73, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12832759

RESUMEN

Thymus and activation-regulated chemokine (TARC) is a CC chemokine that is mainly expressed in the thymus. TARC interacts primarily with the CCR4 receptor and to a lesser extent with the CCR8 receptor. The structures of TARC have been solved by molecular replacement in two space groups, triclinic (P1) and tetragonal (P4(1)), and refined to resolutions of 1.72 and 2.1 A, respectively, with R factors of 19.8% (R(free) = 24.1%) and 19.8% (R(free) = 27.7%), respectively. The search model originated from the crystal structure of another chemokine, RANTES, and proved to be only modestly similar to the refined structure of TARC. Whereas the tetragonal structure was easily solved using the program AMoRe, solution of the triclinic structure proved to be quite challenging and was obtained by combining the results from four different molecular-replacement programs (AMoRe, CNS, BEAST and EPMR), with subsequent extension of the gathered information. The tertiary structure of TARC is similar to that of other CC chemokines, with a three-stranded antiparallel beta-sheet flanked by a C-terminal helix. Both quaternary structures consist of dimers, which in the triclinic crystals pack further into tetramers. The TARC dimers are similar to those observed previously in the crystal structures of both MCP-1 and RANTES.


Asunto(s)
Quimiocinas CC/química , Secuencia de Aminoácidos , Quimiocina CCL17 , Cristalización , Cristalografía por Rayos X/métodos , Glicosaminoglicanos/química , Humanos , Estructura Molecular , Unión Proteica , Conformación Proteica , Alineación de Secuencia
15.
J Biol Chem ; 277(40): 37647-54, 2002 Oct 04.
Artículo en Inglés | MEDLINE | ID: mdl-12149255

RESUMEN

Human macrophage inflammatory protein-3alpha (MIP-3alpha; CCL20) is a CC-type chemokine that binds to and activates CC chemokine receptor-6 (CCR6). Although MIP-3alpha does not share the binding site of CCR6 with any other chemokine, human beta-defensin-1 and -2, small cationic antimicrobial peptides, have also been found to bind to and activate CCR6. Conversely, we have found that MIP-3alpha possesses antibacterial activity of greater potency than human beta-defensin-1 and -2 against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213, while having no activity against the fungus Candida albicans. There is no clear sequence similarity between beta-defensins and the chemokine MIP-3alpha, beyond an abundance of cationic residues and the presence of disulfide bonds. Nonetheless, there are structural similarities between these three proteins that allow their overlap of chemotactic and antimicrobial activities. In this report, we describe the x-ray crystal structure of human MIP-3alpha refined to a resolution of 1.7 A and compare it with the crystal structures of human beta-defensin-1 and -2. Molecules of MIP-3alpha and the beta-defensins seem to share few structural motifs that are likely associated with their common biological activities.


Asunto(s)
Quimiocinas CC/química , Proteínas Inflamatorias de Macrófagos/química , Receptores de Quimiocina/química , beta-Defensinas/química , Secuencia de Aminoácidos , Animales , Antibacterianos , Antiinfecciosos/química , Antiinfecciosos/farmacología , Quimiocina CCL20 , Dimerización , Escherichia coli/efectos de los fármacos , Humanos , Ratones , Pruebas de Sensibilidad Microbiana , Modelos Moleculares , Datos de Secuencia Molecular , Fragmentos de Péptidos , Desnaturalización Proteica , Pliegue de Proteína , Estructura Secundaria de Proteína , Receptores CCR6 , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacología , Staphylococcus aureus/efectos de los fármacos , beta-Defensinas/farmacología
16.
Proc Natl Acad Sci U S A ; 100(15): 8880-5, 2003 Jul 22.
Artículo en Inglés | MEDLINE | ID: mdl-12840147

RESUMEN

Human defensins form a family of small, cationic, and Cys-rich antimicrobial proteins that play important roles in innate immunity against invading microbes. They also function as effective immune modulators in adaptive immunity by selectively chemoattracting T lymphocytes and immature dendritic cells. On the basis of sequence homology and the connectivity of six conserved Cys residues, human defensins are classified into alpha and beta families. Structures of several beta-defensins have recently been characterized, confirming the disulfide connectivity conserved within the family, i.e., Cys1-Cys5, Cys2-Cys4, and Cys3-Cys6. We found that human beta-defensin 3 (hBD3), a recently described member of the growing beta family, did not fold preferentially into a native conformation in vitro under various oxidative conditions. Using the orthogonal protection of Cys1-Cys5 and of Cys1-Cys6, we chemically synthesized six topological analogs of hBD3 with predefined disulfide connectivities, including the (presumably) native beta pairing. Unexpectedly, all differently folded hBD3 species exhibited similar antimicrobial activity against Escherichia coli, whereas a wide range of chemotactic activities was observed with these analogs for monocytes and cells transfected by the chemokine receptor CCR6. Furthermore, whereas substitution of all Cys residues by alpha-aminobutyric acid completely abolished the chemotactic activity of hBD3, the bactericidal activity remained unaffected in the absence of any disulfide bridge. Our findings demonstrate that disulfide bonding in hBD3, although required for binding and activation of receptors for chemotaxis, is fully dispensable for its antimicrobial function, thus shedding light on the mechanisms of action for human beta-defensins and the design of novel peptide antibiotics.


Asunto(s)
beta-Defensinas/química , beta-Defensinas/fisiología , Secuencia de Aminoácidos , Antibacterianos/química , Antibacterianos/farmacología , Línea Celular , Factores Quimiotácticos/química , Factores Quimiotácticos/genética , Factores Quimiotácticos/farmacología , Factores Quimiotácticos/fisiología , Quimiotaxis de Leucocito/efectos de los fármacos , Cisteína/química , Disulfuros/química , Diseño de Fármacos , Escherichia coli/efectos de los fármacos , Humanos , Técnicas In Vitro , Datos de Secuencia Molecular , Ingeniería de Proteínas , Pliegue de Proteína , Homología de Secuencia de Aminoácido , beta-Defensinas/genética , beta-Defensinas/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA